Factors Associated with Discontinuation of Statin Therapy in Patients with Lymphoma Aged 80 Years and Older: A Retrospective Single-Institute Study

BACKGROUND: There is little evidence to support or negate the benefits of statin therapy for primary prevention of cardiovascular disease (CVD) in lymphoma patients aged 80 years or older. OBJECTIVE: We evaluated comprehensive geriatric assessment (CGA) scores and previously reported risk factors fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamasaki, Satoshi, Tokunou, Tomotake, Horiuchi, Takahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205761/
https://www.ncbi.nlm.nih.gov/pubmed/35715688
http://dx.doi.org/10.1007/s40801-022-00314-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205761/
https://www.ncbi.nlm.nih.gov/pubmed/35715688
http://dx.doi.org/10.1007/s40801-022-00314-6

Ejemplares similares